AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
CDT Equity Inc.
Video analysis: CDT
All videosNo video analysis for this stock yet. Request one from our team.
News: CDT
CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that new solid forms and alternative crystal structures of its existing drug compounds, show enhanced physical property advantages, including improved stability, solubility, manufacturability, over existing forms of these compounds.
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has entered into a SAFE note with Pep'd Inc. (“Pep'd”), a US-based peptide company, expanding CDT's exposure to the growing US peptide market (the “Transaction”).
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that it has entered into a strategic transaction to increase its equity stake in Sarborg Limited (“Sarborg”), an agentic AI signature intelligence business operating across multiple industrial sectors, to 22.7% through the issuance of pre-funded warrants to purchase up to 12,131,770 shares of the Company's common stock, subject to shareholder approval at the Company's annual meeting of stockholders on August 28, 2026 (the “Transaction”).
CDT Environmental Technology Announces Results of Extraordinary General Meeting
SHENZHEN, China, July 28, 2026 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (Nasdaq: CDTG) (“CDT”, the “Company”, or “we”), a leading provider of waste treatment systems and services throughout China, today announced that all resolutions of its extraordinary general meeting (the “EGM”) held virtually by electronic means on July 28, 2026 at 9:30 AM., Beijing Time, were duly passed by shareholders.
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the filing of a new patent application covering a large set of field-deployable, two-component combination interventions for sugarcane cultivation, generated through Sarborg's quantum-enabled PRISM platform.
Similar companies
-
Hepion Pharmaceuticals, Inc.
HEPA
·
Other OTC
Compare
-
Longevity Health Holdings Inc.
XAGE
·
Other OTC
Compare
-
ZyVersa Therapeutics, Inc.
ZVSA
·
Other OTC
Compare
-
Envoy Medical, Inc.
COCH
·
NASDAQ
Compare
-
NewGenIvf Group Limited
NIVF
·
NASDAQ
Compare
-
Petros Pharmaceuticals, Inc.
PTPI
·
Other OTC
Compare